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 Altered synaptic transmission with excess glutamate release has been 3 
implicated in the loss of motoneurons occurring in amyotrophic lateral sclerosis 4 
(ALS). Hyperexcitability or hypoexcitability of motoneurons from mice carrying 5 
the ALS mutation SOD1G93A (mSOD1) have also been reported. Here we have 6 
investigated the excitability, ion currents and the kinetics of the exocytotic fusion 7 
pore in chromaffin cells from P90 to P130 days old mSOD1 mice, when motor 8 
deficits are already established. With respect to wild type (WT), mSOD1 9 
chromaffin cells had a decrease in the following parameters: 95% in 10 
spontaneous action potentials, 70% in nicotinic current for ACh, 35% in Na+ 11 
current, 40% in Ca2+-dependent K+ current, 53% in voltage-dependent K+ 12 
current. Ca2+ current was increased by 37% but the ACh-evoked elevation of 13 
cytosolic Ca2+ was unchanged. Single exocytotic spike events triggered by ACh 14 
had the following differences (mSOD1 versus WT): 36% lower rise rate, 60% 15 
higher decay time, 51% higher half-width, 13% lower amplitude, and 61% 16 
higher quantal size. The expression of the α3 subtype of nicotinic receptors and 17 
proteins of the exocytotic machinery was unchanged in the brain and adrenal 18 
medulla of mSOD1, with respect to WT mice. A slower fusion pore opening, 19 
expansion, and closure is likely linked to the pronounced reduction in cell 20 
excitability and in the ion currents driving action potentials in mSOD1, compared 21 
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The selective loss of motoneurons is central-stage in the pathogenesis of 34 
amyotrophic lateral sclerosis (ALS). This leads to muscle weakness, atrophy, 35 
and spasticity that end up into paralysis, respiratory insufficiency, and patient 36 
death in less than 5 years (53). Most ALS cases are sporadic but about 10% of 37 
patients have a positive family history; of these, 20% have mutations in the 38 
gene for Cu2+/Zn2+ superoxide dismutase 1 (SOD1). When modelled in mice, 39 
the mutation G93A (glycine to alanine at codon 93) (mSOD1) show adult 40 
disease onset from P90 onwards and reproduces the clinical paralytic 41 
symptoms of ALS (22, 23), with significant loss of motoneurons (9). 42 
 43 
Why motoneurons die in ALS is unknown. The excitotoxic hypothesis 44 
implies excess glutamate release in both patients and transgenic mice (6, 31, 45 
52, 56, 60). This will lead to altered Ca2+ homeostasis, excess production of 46 
free radicals, and apoptotic death of motoneurons (18, 44, 62). Consistent with 47 
this is the fact that riluzole, the only medicine so far approved to treat ALS (2, 48 
53), inhibits the exocytotic release of glutamate (38). Also, it has been reported 49 
that cerebrospinal fluid of ALS patients augments the basal concentration of 50 
cytosolic calcium ([Ca2+]c) and elicits motoneuron death (65). 51 
 52 
The excitotoxic hypothesis implies that a chronically hyperexcitable 53 
motoneuron would fire more action potentials (APs) and consequently more 54 
Ca2+ will enter into its cytoplasm, eventually eliciting its death (27, 33, 62). 55 
Some reports suggest that embryo motoneurons and cortical neurons of 56 
mSOD1 mice are hyperexcitable (33, 48, 50). However, other reports show 57 
normal excitability at neonatal age (51) or even hypoexcitability at adult P30-58 
P80 mSOD1 mice (14). 59 
 60 
We here propose the hypothesis that a more general alteration in the fine 61 
tuning of neuronal excitability and the exocytotic machinery may underlie the 62 
pathogenic features of ALS, and that these alterations could also be present in 63 
adrenal chromaffin cells. In fact, altered exocytosis in chromaffin cells have 64 
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been shown in the APP/PS1 mouse model of Alzheimer’s disease (AD) (13), in 65 
the knock-out mouse model of the huntingtin-associated protein 1 (HAP1), a 66 
model of Huntington’s disease (HD) (35), and in mice carrying specific 67 
mutations in proteins of the exocytotic machine (55, 59). We have studied here 68 
the cell excitability, ion currents, Ca2+ signals, and the quantal release of 69 
catecholamine in chromaffin cells from wild type (WT) and mSOD1 mice. We 70 
have found a pronounced depression of cell excitability and ion currents 71 
associated to a slow kinetics of the fusion pore with higher quantal size, in 72 
mSOD1 compared with WT chromaffin cells.  73 
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Experiments were conducted according to the recommendation of the 78 
Ethics Committee from Universidad Autónoma de Madrid on the use of animals 79 
for laboratory experimentation, in accordance with the code of ethics and 80 
guidelines established by European Community Directive (2010/63/EU) and 81 
Spanish legislation (RD53/2013). All efforts were made to avoid animal suffering 82 
and to use the minimum number of animals allowed by the experimental 83 
protocol and the statistical power of group data. Mice were housed individually 84 
under controlled temperature and lighting conditions with food and water 85 
provided ad libitum and housed on a 12:12 h light cycle.  86 
 87 
Male B6.Cg-Tg(SOD1-G93A)1Gur/J mice, hereafter referred to as 88 
mSOD1, were purchased from The Jackson Laboratory, Bar Harbor, Maine 89 
(stock #004435). These mice over-express a point mutated form of the human 90 
SOD1 gene (single amino acid substitution of glycine to alanine at codon 93) 91 
driven by the endogenous human promoter. Offspring hemizygous for the 92 
mutant SOD1 transgene used in this study were produced by strict crossings of 93 
hemizygous male SOD1G93A mice with wild-type C57BL/6J inbred females to 94 
maintain the mutant transgene on a C57BL/6 congenic background. We trust 95 
“The Jackson Laboratory's Genotype Promise” that ensures the right 96 
genotyping of the animals. The same number of C57BL/6J wild type mice, 97 
hereafter referred to as WT, were used as controls. Mice were used at postnatal 98 
days P90 to P130 and henceforth will be referred to as P100; at this age the 99 
animals show adult disease onset (22, 23) and significant loss of vulnerable 100 
spinal motoneurons (9). 101 
 102 
Primary culture of mouse chromaffin cells 103 
 104 
Mice were sacrificed by cervical dislocation. Both adrenal glands from a 105 
mouse were rapidly collected and placed in ice-cold Locke’s solution of the 106 
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following composition (in mM): 154 NaCl, 5.5 KCl, 3.6 NaHCO3, 10 HEPES and 107 
5.5 D-glucose (pH 7.4, NaOH). Glands were fat-trimmed and medullae were 108 
isolated by removing the cortex. Then the medullae were placed in a tube 109 
containing 200 µL Locke’s solution with papain (25 U/ml) for tissue digestion 110 
during 30 min. This solution was exchanged by 1 ml DMEM, repeating the 111 
exchange 3 times and leaving finally 120 µl of DMEM. Then medullae were 112 
minced first with a 1 ml micropipette and then with a 200 µl micropipette. Finally, 113 
the residual medulla fragments were discarded and 10-20 µl drops of cell-114 
containing solution from the minced extracts were plated on poly-D-lysine-115 
coated coverslips of one or two 12-well plates. After 30 min in an incubator (37 116 
°C, water-saturated and 5% CO2 atmosphere) 1 ml DMEM supplemented with 117 
5% fetal bovine serum, 50 IU/ml penicillin, and 50 µg/ml streptomycin were 118 
added to each well and remained in the incubator for 1 to 2 days during which 119 
experiments were done. 120 
 121 
Monitoring of cell excitability and ion currents  122 
 123 
Recordings of membrane potential (Vm) and APs were made under the 124 
current-clamp mode in the whole-cell configuration of the patch-clamp 125 
technique (24), which allows the observation of spontaneous variations in the 126 
Vm. Cells were superfused with control Tyrode solution at pH 7.4 containing (in 127 
mM): 137 NaCl, 1 MgCl2, 2 CaCl2 and 10 HEPES/NaOH; an intracellular 128 
solution at pH 7.4 containing (in mM) 135 KCl, 10 NaCl, 10 HEPES, 1 MgCl2 129 
and 5 EGTA was introduced in the patch-clamp pipette. 130 
 131 
Inward currents through nicotinic receptor ion channels (IACh), voltage-132 
activated sodium channels (INa), voltage-activated calcium channels (ICa), 133 
voltage-activated potassium channels (IK(V)) and calcium-dependent potassium 134 
channels (IK(Ca)) were recorded using the voltage-clamp mode of the whole-cell 135 
configuration of the patch-clamp technique (24). Whole-cell recordings were 136 
made with fire-polished borosilicate pipettes (resistance 2-5 MΩ) that were 137 
mounted on the headstage of an EPC-9 patch-clamp amplifier (HEKA 138 
Electronic, Lambrecht, Germany), allowing cancellation of capacitative 139 
7 
 
transients and compensation of series resistance. Data were acquired with a 140 
sample frequency of 20 kHz by using PULSE 8.74 software (HEKA Elektronik). 141 
The data analysis was performed with Igor Pro (Wavemetrics, Lake Oswego, 142 
OR, USA) and PULSE programs (HEKA Elektronik). Coverslips containing the 143 
cells were placed on an experimental chamber mounted on the stage of a Nikon 144 
Diaphot inverted microscope. Cells were continuously superfused with a control 145 
Tyrode solution at pH 7.4 containing (in mM): 137 NaCl, 1 MgCl2, 2 CaCl2 and 146 
10 HEPES/NaOH. Once the patch membrane was ruptured and the whole-cell 147 
configuration of the patch-clamp technique had been established, the cell was 148 
locally, rapidly and constantly superfused with an extracellular solution of similar 149 
composition to the chamber solution, but containing nominally 0 mM Ca2+ to 150 
measure INa, and 2 mM Ca
2+ to measure IACh, ICa and IK.  151 
 152 
Cells were internally dialysed with an intracellular solution containing (in 153 
mM): 100 CsCl, 14 EGTA, 20 TEA-Cl, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 154 
HEPES/CsOH (pH 7.3) for the recording of INa, ICa and IACh; for recording IK the 155 
intracellular solution had the following composition (in mM): 135 KCl, 14 EGTA, 156 
10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES⁄KOH (pH 7.3). The external 157 
solutions were rapidly exchanged using electronically driven miniature solenoid 158 
valves coupled to a multi-barrel concentration clamp device, the common outlet 159 
of which was placed within 100 μm of the cell to be patched. The flow rate was 160 
1 ml/min and was regulated by gravity. 161 
 162 
For measuring the different currents, cells were held at −80 mV; INa was 163 
generated by 10 ms depolarising pulses to −10 mV, ICa was generated by 50 ms 164 
depolarising pulses to −10 or 0 mV; IACh was generated by the application of 165 
250 ms ACh pulses (100 μM), and IK was generated by the application of a 10 166 
ms pre-depolarising command to +30 mV followed by a 400 ms full 167 
depolarisation pulse to +120 mV. All experiments were performed at room 168 
temperature (24 ± 2 °C) on cells from 1 to 2 days after culture. 169 
 170 




Chromaffin cells were incubated for 1 h at 37 °C in DMEM medium 173 
containing the calcium probe fura-2 acetoxymethyl ester (fura-2AM; 10 μM). 174 
After this incubation period, the coverslips were mounted in a chamber and cells 175 
were washed and covered with Tyrode solution. The setup for fluorescence 176 
recordings was composed of a Leica DMI 4000 B inverted light microscope 177 
(Leica Microsystems; Barcelona, Spain) equipped with an oil immersion 178 
objective (Leica 40× Plan Apo; numerical aperture 1.25). Once the cells were 179 
placed on the microscope, they were continuously superfused by means of a 180 
five-way superfusion system at 1 ml/min with a common outlet 0.28 mm-tube 181 
driven by electrically controlled valves with Tyrode solution. Fura-2AM was 182 
excited alternatively at 340 ± 10 and 387 ± 10 nm using a Küber CODIX xenon 183 
arc lamp (Leica). Emitted fluorescence was collected through a 540 ± 20 nm 184 
emission filter and measured with an intensified charge coupled device camera 185 
(Hamamatsu camera controller C10600 orca R2; Japan). Fluorescence images 186 
were generated at 1-s intervals. All experiments were performed at room 187 
temperature (24 ± 2 °C) on cells from 1 to 2 days after culture. 188 
 189 
Amperometric recordings 190 
 191 
Quantal release of catecholamine was measured with amperometry (10, 192 
64). Electrodes were built as previously described (30) by introducing a 10 µm 193 
diameter graphite fibre (Amoco, now part of BP-Group, London, UK) into glass 194 
capillary tubes (Kimble-Kontes, Vineland, NJ, USA). These tubes were then 195 
pulled (Narishige PC-10 pipette puller, Narishige, Tokyo, Japan), and the 196 
carbon fibre was inserted in both thin ends of the pulled tube and was cut with a 197 
pair of small scissors obtaining thus two pipettes with a carbon fibre piece 198 
sticking out of each tip. The tip was sealed by a two-component epoxy 199 
(EPIKOTE 828-Miller-Stephenson, Danbury, CT, USA); and m-200 
phenylendiamine, 14% (Aldrich, Steimheim, Germany). The electrodes were left 201 
overnight to dry, introduced into an oven at 100 °C for 2 h, and then kept 202 
another 2 h at 150 °C. The amperometer was homemade (UAM workshop, 203 
Madrid, Spain) and connected to an interface (PowerLab/4SP, ADInstruments, 204 
Oxford, UK) that digitised the signal at 10 kHz sending it to a personal computer 205 
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that displayed it within the Pulse v8.74 software (HEKA Elektronik). A 700-mV 206 
potential was applied to the electrode with respect to an AgCl ground electrode. 207 
The electrodes were calibrated following good amperometric practices (36) by 208 
perfusing 50 µM norepinephrine dissolved in standard Tyrode and measuring 209 
the current elicited; only electrodes that yielded a current between 200 and 400 210 
pA were used. The coverslips were mounted in a chamber on a Nikon Diaphot 211 
inverted microscope used to localise the target cell, which was continuously 212 
superfused by means of a five-way superfusion system with a common outlet 213 
driven by electrically controlled valves, with a Tyrode solution composed of (in 214 
mM) 137 NaCl, 1 MgCl2, 5 KCl, 2 CaCl2, 10 HEPES and 10 glucose (pH 7.4, 215 
NaOH). The high K+ solutions were prepared by replacing equiosmolar 216 
concentrations of NaCl with KCl. At the time of experiment performance, proper 217 
amounts of drug stock solutions were freshly dissolved into the Tyrode solution. 218 
All experiments were performed at room temperature (24 ± 2 °C) on cells from 1 219 
to 2 days after culture. 220 
 221 
Immunoblotting and image analysis of the expression of proteins of the 222 
exocytotic machinery and the α3 subunit of nicotinic receptors 223 
 224 
Motor cortex, hippocampus, spinal cord and adrenal glands were 225 
removed from the mice, and membrane proteins were extracted using the 226 
MEM-PERTM Membrane Protein Extraction Kit (Thermo Scientific, Rockford, IL, 227 
USA) following the manufacturer´s instructions. At all times, proteins were in the 228 
presence of protease inhibitors (HaltTM Protease Inhibitor Cocktail; Thermo 229 
Scientific). Proteins were quantified using the Bicinchoninic Acid Protein Assay 230 
(G-Biosciences, St. Louis, MO, USA). Proteins (20 µg) were resolved by SDS-231 
PAGE (12%) and transferred to Immobilon-P® Transfer Membrane (Millipore 232 
Corporation, Billerica, MA, USA). Membranes were blocked in Tris-buffered 233 
saline with 0.05% Tween® 20 containing 4% bovine serum albumin, and 234 
incubated for 2 h at room temperature with primary antibodies anti-235 
synaptotagmin 1 (SYT1, 1:200), anti-synaptotagmin 7 (SYT7, 1:200), anti-236 
syntaxin 1 (STX1, 1:200), anti-synaptosomal-associated protein 25 (SNP25, 237 
1:200), anti-vesicle-associated membrane protein 2 (VAMP2, 1:200) and anti-238 
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neuronal ACh receptor subunit α3 (NACHRA3, 1:200), all of them from Santa 239 
Cruz Biotechnology (Dallas, TX, USA), and with anti-β-actin (1:100.000; Sigma-240 
Aldrich, St. Louis, MO, USA) as loading control; then, for 45 min with secondary 241 
antibodies conjugated with peroxidase (1:10.000; Santa Cruz Biotechnology). 242 
The membrane was developed using the ECL SelectTM Western Blotting 243 
Detection Reagent (GE Healthcare, Chalfont St. Giles, UK). Different band 244 
intensities corresponding to immunoblot detection of protein samples were 245 
quantified using Scion Image® Alpha 4.0.3.2 programme (Scion Corporation, 246 
USA). 247 
 248 
Rota-Rod test 249 
 250 
The Rota-Rod apparatus (Stoelting Co., Wood Dale, IL, USA) was used 251 
to assess motor performance. Mice were challenged with an initial speed of 8 252 
rpm and an increase of 1 rpm each 8 seconds until they fell down. The time 253 
spent walking on the Rota-Rod was measured and time from 10 repetitions was 254 
averaged; 180 seconds was chosen as the arbitrary cut-off time. Mice were 255 
trained for 1 day (training day, Trd) to get acquainted with the Rota-Rod 256 
apparatus for the test day (Td) in consecutive days. Different mice at P90 and 257 
P130 ages were used.  258 
 259 
Statistical analysis 260 
 261 
 Ion currents and cell excitability data analysis were performed using the 262 
GraphPad Prism version 5.01 for Windows (GraphPad Prism Software, San 263 
Diego, CA, USA). Student’s t-test or one-way ANOVA followed by Tukey or 264 
Dunnett post hoc tests were used to determine statistical signiﬁcance between 265 
means. *P < 0.05 was taken as the limit of significance; ** and *** show a 266 
statistical significance of P < 0.01 and P < 0.001, respectively. 267 
  268 
 Data from measurement of changes in the [Ca2+]c was obtained from 269 
LAS AF software and Ascent software version 2.4.2. Graphs and the 270 
mathematical analyses were performed using the GraphPad Prism software, 271 
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version 5.01 (GraphPad Software Inc.). Areas were calculated by integrating the 272 
[Ca2+]c transient over time during the stimulus duration by means of Origin Pro 8 273 
SR2 software, version 8.0891 (OriginLab Corporation, Northampton, MA, USA). 274 
Areas were worked out by the integration of the input data set by using the 275 
trapezoidal rule. Results shown in the text and figures are expressed as mean ± 276 
SEM Statistical analyses were carried out with one-way ANOVA test and Tukey 277 
post-hoc analyses. *P < 0.05 was taken as the limit of significance; ** and *** 278 
show a statistical significance of P < 0.01 and P < 0.001, respectively. 279 
 280 
Amperometry data analysis was carried out on a personal computer 281 
using Excel software (Microsoft, Redmond, WA, USA) and IgorPro software 282 
(Wavemetrics). Total amperometric quantal charge was calculated by 283 
integrating the amperometric current over time during the stimulus duration with 284 
a homemade macro written in IgorPro software. The number of spikes greater 285 
than 5 pA was manually counted on an extended graph displayed in the 286 
computer screen. A ruler was drawn at 5 pA and only the spikes going above 287 
the threshold amplitude were considered. The kinetic analysis of single 288 
amperometric events (spikes) was performed as previously described (21) 289 
using a macro written in IgorPro software (41). Median values for all the spikes 290 
of each cell were obtained and then pooled together for statistical comparison; 291 
this method helps overcoming the large variability in spike number and spike 292 
kinetics by giving each cell the same weight independently of the number of 293 
spikes produced. Differences between means of group data fitting a normal 294 
distribution were assessed by using either analysis of variance or Kruskal-Wallis 295 
test for comparison among multiple groups or Student’s t test for comparison 296 
between two groups. *P < 0.05 was taken as the limit of significance; ** and *** 297 
show a statistical significance of P < 0.01 and P < 0.001, respectively. 298 
 299 
Comparisons between groups from immunoblotting and image analysis 300 
of the expression of proteins, were performed by one-way analysis of variance 301 
(ANOVA) followed by the Newman-Keuls post hoc test or by the unpaired 302 
Student’s t-test using the Graph Pad Prism software version 5.01. */#P < 0.05 303 
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was taken as the limit of significance. ** and *** show a statistical significance of 304 
P < 0.01 and P < 0.001, respectively.  305 
 306 
Data from Rota-Rod test are means from 10 repetitions of Trd and Td of 307 
different mice at P90 and P130 ages. *P < 0.05 was taken as the limit of 308 
significance; ** and *** show a statistical significance of P < 0.01 and P < 0.001, 309 
respectively. 310 
 311 
Materials and chemicals 312 
 313 
 The calcium binding probe fura-2AM was purchased from Invitrogen 314 
(Eugene, OR, USA). Acetylcholine chloride and all other chemical components 315 
used in this study for cell cultures and the various experiments were obtained 316 





 To discern about possible differences in the stimulus-secretion coupling 320 
process been WT and mSOD1 chromaffin cells, we explored the various steps 321 
in the chain of events involved in such process. Those steps include chromaffin 322 
cell excitability and the firing of spontaneous APs, ion currents, [Ca2+]c 323 
transients, and the exocytotic release of catecholamine, including the kinetic 324 
analysis of the single-vesicle amperometric spike. With the thorough analysis of 325 
those events we expected to raise a hypothesis to explain the changes in the 326 
quantal release of catecholamines. Furthermore, although ACh and high-K+ 327 
quantitatively elicit similar Ca2+-dependent catecholamine release responses 328 
(17) we later on showed that the Ca2+ transients and the secretory responses 329 
elicited by ACh and K+ considerably differed (8). Thus we analysed here the 330 
[Ca2+]c transients and the kinetics of the quantal release of catecholamine in 331 
chromaffin cells from WT and mSOD1 mice stimulated with ACh or high-K+. 332 
 333 
Excitability of chromaffin cells from WT and mSOD1 mice 334 
 335 
 To determine the resting Vm, cells were sealed under the voltage-clamp 336 
mode and held at a potential of −80 mV until series resistance was lower than 337 
20 MΩ. Then the amplifier was switched to current-clamp mode and current 338 
injection set to 0 pA. In 15 cells from 6 different WT mice, Vm was −67.8 ± 2.05 339 
mV and in 31 cells from 7 different mSOD1, Vm was −62.85 ± 1.9 mV (Figure 340 
1D). These values agree with those found in chromaffin cells from various 341 
animal species that ranged between −50 and −80 mV (reviewed in 12). 342 
 343 
 In spite of the fact they had similar Vm, the firing of spontaneous APs 344 
considerably differed in chromaffin cells of WT and mSOD1 mice. For instance, 345 
the example WT cell of Figure 1A had a Vm of around −60 mV and initially fired 346 
a burst of high-rate APs during the first 70 s; thereafter, the cell had silent 347 
periods with a few scattered APs. Figure 1B corresponds to an example 348 
mSOD1 cell with only a few APs scattered along the 5-min recording period. In 349 
15 WT cells from 6 different mice, we counted 57.6 ± 12 APs during the 5 min 350 
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recording period; in sharp contrast, in the 31 mSOD1 cells from 7 mice we only 351 
counted 2.6 ± 1 APs (Figure 1C). 352 
 353 
Whole-cell ion currents of chromaffin cells from WT and mSOD1 mice 354 
 355 
 Whole-cell ion currents were recorded in WT and mSOD1 chromaffin 356 
cells voltage-clamped at −80 mV. IACh were elicited by the application of a 250 357 
ms pulse of an extracellular solution containing 100 µM ACh. ACh pulses were 358 
applied at regular 2 min intervals. Figure 2A shows the IACh traces generated by 359 
the application of 5 sequential pulses of ACh to an example WT cell. Figure 2B 360 
shows 5 IACh traces obtained on an example mSOD1 cell showing a smaller 361 
peak amplitude. Two example IACh obtained from a WT and a mSOD1 cell are 362 
displayed in Figure 2C; in both cases, current inactivation is likely due to the 363 
well known desensitisation of nicotinic receptors upon their exposure to ACh 364 
(29, 46). In 13 cells from 4 WT mice, IACh peak was 3.87 ± 0.32 nA while in 43 365 
cells from 9 mSOD1 mice was 1.16 ± 0.06 nA, a 70% diminution (Figure 2D). 366 
 367 
 IK were investigated using a two-step depolarising pulse protocol. First, a 368 
10 ms pre-depolarising command to +30 mV was given in order to allow Ca2+ 369 
entry and the activation of the calcium-dependent component of IK; then, a 400 370 
ms depolarising pulse to +120 mV was applied to recruit both the Ca2+-371 
dependent and the voltage dependent components of IK (see protocol on top of 372 
Figure 2E). The IK traces of Figure 2E were taken from a WT and mSOD1 cell 373 
subjected to the two-step depolarising pulse protocol. Initially there is a large 374 
outward current component that inactivates in about 100 ms to a sustained 375 
plateau; these two components are due, respectively, to activation of IK(Ca) and 376 
activation of IK(V). IK(Ca) is activated by the [Ca
2+]c transient generated by the pre-377 
pulse and inactivates upon clearance of such transient to give rise to the 378 
sustained plateau, that is due to voltage-dependent K+ channels, which remain 379 
open for the entire 400 ms depolarising pulse (45). Figure 2E shows that IK(Ca) 380 
and IK(V) components of IK were present in mSOD1 cells; they however were 381 
substantially lower than those recorded in the WT cell. These differences are 382 
better illustrated in the bar diagram of Figure 2F. Thus, the averaged IK(Ca) 383 
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component of 30 cells from 5 WT mice was 6.25 ± 0.46 nA compared with 3.75 384 
± 0.47 nA in 8 cells from mSOD1 mice, a 40% diminution; the values for the IK(V) 385 
component were 2.4 ± 0.13 nA and 1.12 ± 0.22 nA, for WT and mSOD1 cells, 386 
respectively (a 53% diminution).  387 
 388 
 ICa were generated by application of 50 ms test depolarising pulses to 0 389 
mV, as shown in the protocol on top of Figure 3A; in this panel, two 390 
superimposed current traces from example WT and mSOD1 cells, with their 391 
initial rapidly inactivating INa and later slow-inactivating ICa, are shown. Averaged 392 
peak amplitude of ICa for WT and mSOD1 cells is shown in Figure 3B, with 170 393 
± 21.6 pA for WT cells and 270 ± 28.1 pA for mSOD1 cells, a 37% increase. No 394 
differences of current kinetics between both cell types were observed. 395 
 396 
 Finally, INa were generated with test depolarising pulses to −10 mV, given 397 
at 10 s intervals. INa traces obtained in WT and mSOD1 cells are shown in 398 
Figure 3C; peak INa amplitude was 20% smaller in the latter, respect to the 399 
former. Pooled data from 49 cells of 6 WT mice gave an INa peak amplitude of 400 
1.41 ± 0.12 nA, while in 25 cells from 6 mSOD1 mice INa averaged 0.92 ± 0.08 401 
nA, a 35% decrease (Figure 3D). 402 
 403 
Cytosolic calcium transients generated by cell depolarisation with acetylcholine 404 
or high-potassium in chromaffin cells from WT and mSOD1 mice 405 
 406 
 It is well established that ACh and high K+ cause cell depolarisation, 407 
enhanced Ca2+ entry through voltage-activated calcium channels (VACCs), 408 
elevation of [Ca2+]c, and the activation of the exocytotic release of 409 
catecholamine from chromaffin cells (1, 12, 15, 43). From a quantitative point of 410 
view, ACh and high K+ trigger similar catecholamine release responses; 411 
however, the [Ca2+]c transients generated by these two secretagogues are quite 412 
different (8). Therefore, we next explored the [Ca2+]c transients generated by 413 
ACh and high K+ in fura-2AM loaded WT and mSOD1 chromaffin cells. After an 414 
initial 3 min period to get a stable resting baseline, cells were challenged with 415 
Tyrode solutions containing supramaximal depolarising ACh concentrations 416 
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(100 µM) or high K+ (75 mM) during 1 min. This protocol was similar to that 417 
used to monitor the quantal release of catecholamine (see later). A given cell 418 
was stimulated with ACh or K+ only once. 419 
  420 
 Example records of the time course of the [Ca2+]c elevations produced by 421 
ACh and K+ in WT and mSOD1 chromaffin cells are shown in Figure 4A and 4B, 422 
respectively. Although the ACh-evoked [Ca2+]c transients were similar in WT 423 
and mSOD1 cells, the K+-evoked [Ca2+]c transients were notably higher in 424 
mSOD1 cells, with respect to WT cells. This is better illustrated in the bar 425 
graphs of Figure 4C,D and E, showing that in WT and mSOD1 cells challenged 426 
with ACh time to peak (tmax), peak amplitude, and area are similar for both types 427 
of cells. This was not the case for K+; in mSOD1 cells tmax is 20% lower with 428 
respect to WT cells. However, peak amplitude and area are 88 and 100% 429 
higher, respectively. Thus, the K+-elicited [Ca2+]c transient had a faster 430 
activation as well as almost 2-fold enhanced [Ca2+]c in mSOD1 with respect to 431 
WT cells. This agrees with the higher ICa current observed in mSOD1 cells with 432 
respect to WT cells (Figure 3B). 433 
 434 
Quantal catecholamine release responses triggered by acetylcholine or high 435 
potassium in chromaffin cells from WT and mSOD1 mice 436 
 437 
 To study the quantal release of catecholamine, all experiments began 438 
with an initial 5 min perifusion resting period with a standard Tyrode solution for 439 
adaptation of the targeted cell to its environment. None or few spontaneous 440 
amperometric secretory spikes were usually seen during this period. To 441 
stimulate exocytosis, the basal Tyrode solution containing 2 mM Ca2+ was 442 
quickly switched to another containing 100 µM ACh or 75 mM K+ that bathed 443 
the cell for 1 min. This long stimulation period was used for two reasons: (1) we 444 
sought to get the maximal number of spikes to augment the power of statistical 445 
analysis of single exocytotic events; and (2) we also wished to explore potential 446 
differences in the time course of secretion linked to vesicle pool exhaustion 447 
and/or to the inactivation of VACCs (25, 61). A given cell from a culture dish 448 
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was stimulated with ACh only once. About 75% of the tested mSOD1 cells and 449 
85% of the WT cells responded to ACh. 450 
 451 
 Figure 5A shows the spike burst produced by ACh in an example control 452 
cell; baseline was stable during the burst indicating the absence of overlapping 453 
spikes. Figure 5B shows a spike record from an example mSOD1 cell. Once 454 
more, in this cell no baseline elevation was produced although an initial high-455 
frequency spike burst occurred; this was followed by a period with few spikes. 456 
Pooled data on cumulative secretion versus time calculated at 5 s intervals from 457 
experiments similar to those shown in the example records of Figure 5A,B were 458 
plotted in Figure 5C. In both cell types an initial faster rate of secretion during 459 
the first 10 s of the ACh pulse was followed by slower secretion rates that were 460 
slowly increasing along the next 50 s period. In mSOD1 cells the initial secretion 461 
rate was 21.7% slower (time constant for activation, τa = 13.72 s) as compared 462 
with WT cells (τa = 11.27 s). The integrated secretion (area in pC of all spikes 463 
secreted by each ACh pulse) is plotted in Figure 5D; this total secretion was 464 
46.6% higher in mSOD1 cells. However, in spite of this difference, the number 465 
of spikes per ACh stimulus was similar, 24.55 ± 2.22 for WT cells and 21.06 ± 466 
1.22 for mSOD1 cells (Figure 5E). The quantal size (single-vesicle content of 467 
catecholamine, Q) was 1.6-fold higher in mSOD1 cells (0.47 ± 0.03 pC) with 468 
respect to WT cells (0.31 ± 0.02 pC) (Figure 5F and Table 1). Thus, this higher 469 
total secretion with similar spike numbers could be explained by this greater 470 
quantal size of mSOD1 with respect to WT cells. 471 
 472 
 Concerning K+ stimulation (75 mM, 1 min), most WT and mSOD1 (>95%) 473 
responded to this stimulus. The example WT cells displayed in Figure 6A,B 474 
generated an initial spike burst followed by more infrequent spikes, indicating a 475 
slower rate of secretion at later stages of the K+ stimulation period. Of note was 476 
baseline elevation at the beginning of the K+ pulse, suggesting the presence of 477 
overlapping spikes due to fast almost simultaneous exocytosis of docked 478 
vesicles of a readily releasable vesicle pool (RRP) (21, 40, 43). Cumulative 479 
secretion versus time measured at 5 s intervals was plotted in Figure 6C. Unlike 480 
for ACh, the initial secretion was similar in WT cells (τa = 10.71 s) and mSOD1 481 
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cells (τa = 10.75 s). The two curves run in parallel and exhibited a low rate of 482 
increasing secretion. The integrated secretion (area in pC of all spikes secreted 483 
per each K+ pulse) is plotted in Figure 6D; this secretion was similar in both cell 484 
types, around 12-13 pC. The total spike number (20.44 ± 1.98 for WT and 23.8 485 
± 1.76 for mSOD1) (Figure 6E) and the Q (0.4 ± 0.02 pC for WT and 0.42 ± 486 
0.03 pC for mSOD1) were also similar (Figure 6F and Table 1). 487 
 488 
 Spike frequency histograms counted at 2 s intervals during the 60 s 489 
stimulation periods with ACh or K+, are shown in Figure 7A-D. The decay of the 490 
rate of spike frequency was best fitted to a single exponential in WT and 491 
mSOD1 cells. With ACh stimulation the time constant for inactivation (τi) of 492 
spike frequency was 8.1 s and 8.23 s, respectively, for WT and mSOD1 cells; in 493 
the case of K+, τi amounted to 4.43 s and 5.36 s for WT and mSOD1 cells, 494 
respectively (Figure 7E). Thus, the inactivation rate was 15% and 12% slower in 495 
mSOD1 cells, respectively for ACh or K+. Of note was the fact that spike 496 
frequency with ACh had a smaller plateau in mSOD1 cells (0.77%) than in 497 
control cells (1.26%) (Figure 7A,B). These differences were not apparent with 498 
K+ (1.02% versus 1.17%, for WT and mSOD1 cells, respectively) (Figure 7C,D). 499 
 500 
Types of secretory spike events in chromaffin cells from WT and mSOD1 mice 501 
 502 
 We next counted and analysed the different types of spike events 503 
present in secretory traces generated by 1-min stimulation with ACh or K+. 504 
Figure 9 shows examples of the different subtypes of spikes analysed, and 505 
Table 2 contains pooled results on the relative percentage of the different 506 
subtypes of spikes analysed. With ACh stimulation, spikes with foot were 507 
59.56% and 65.71% for WT and mSOD1 cells, respectively. With K+, the 508 
number of spikes with foot was similar in both cell types, around 70% (no 509 
statistically significant difference). Although an increase of spikes with foot 510 
seemed apparent in mSOD1 cells (65.71% with ACh and 73.1% with K+), these 511 
differences were only statistically significant with ACh compared with the values 512 
of WT cells (59.56% with ACh and 67.94% with K+). We also compared values 513 
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of ACh and K+ stimuli and differences were statistically significant both in WT 514 
and mSOD1 cells (Table 2). 515 
 516 
 Multiple spike events (overlapping spikes) indicate near-simultaneous 517 
quantal catecholamine release from vesicles belonging to a RRP. For instance, 518 
in a previous study we found as much as 30% overlapping spikes in cells from 519 
spontaneously hypertensive rats (SHRs) that likely had a larger RRP and hence 520 
they responded with massive exocytotic events upon their stimulation with ACh 521 
or K+; in contrast, cells from normotensive rats had only 15% of overlapping 522 
spikes (40). Compared with the rat, cells from control mice had only 3.91% of 523 
multiple spike events when stimulated with ACh and around 5.69% when 524 
stimulated with K+ (Figure 9B,C, Table 2). Similar values were obtained in cells 525 
from mSOD1 (4.15% and 5.09%, respectively) (Figure 9E,F, Table 2). Flickers 526 
are defined as small amounts of catecholamine release through a narrow fusion 527 
pore that opens transiently. Examples of these flickers are shown in Figure 528 
9B,C (WT cells stimulated respectively with ACh or K+) and in Figure 9E,F 529 
(mSOD1 cells stimulated respectively with ACh or K+). We found that 69.8% of 530 
ACh-elicited secretory responses from control cells had at least 1 flicker; this 531 
was higher than the value of 60.3% obtained when these cells were stimulated 532 
with K+. Of those, 6.9% and 7.52% of the total spike number were flickers. On 533 
the other hand, 69.6% and 82.4% of mSOD1 cells stimulated with ACh and K+ 534 
had 1 flicker at least, and flickers were 8.84% and 8.13% of the total spike 535 
number, respectively (Table 2). 536 
 537 
Kinetic analysis of single exocytotic events occurring in the secretory responses 538 
triggered by acetylcholine and high potassium in chromaffin cells from WT and 539 
mSOD1 mice 540 
 541 
Figure 8A shows a schematic model of an amperometric secretory spike 542 
with foot, indicating the parameters that we measured according to the criteria 543 
established by Machado et al. (36) for good practices in single-cell 544 
amperometry. Four types of comparative analyses were performed: (i) WT 545 
(2034 spikes, 63 cells) versus mSOD1 cells (1357 spikes from 69 cells) 546 
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stimulated with ACh; (ii) WT (1848 spikes, 58 cells) versus mSOD1 cells (1761 547 
spikes, 74 cells) stimulated with K+; (iii) WT cells stimulated with ACh versus K+ 548 
and (iv) mSOD1 cells stimulated with ACh versus K+. 549 
 550 
(i) All parameters studied on WT and mSOD1 cells indirectly 551 
depolarised with the physiological neurotransmitter ACh, exhibited statistically 552 
significant differences (Table 1). Thus, compared with WT, mSOD1 cells had 553 
the following changes: 35.94% lower rise rate, 60.7% longer decay time, 55.3% 554 
higher half-amplitude time (half-width, t1/2), 16.62% lower amplitude (Imax), and 555 
52.24% higher Q. Averaged spikes with these parameters resulted in a 556 
narrower but faster spike for WT cells, compared with a slower spike with higher 557 
Q for mSOD1; this indicated a slower but higher exocytotic release of 558 
catecholamine per single vesicle in the latter, compared with the former as 559 
indicated in the averaged overlapping spikes of Figure 8B. 560 
 561 
(ii) Surprisingly, all kinetic parameters of spikes recorded from WT 562 
and mSOD1 cells directly depolarised with K+ had similar values (Table 1). This 563 
indicated that the averaged exocytotic spike did not differ between both cell 564 
types when they were directly depolarised with K+, as the overlapping averaged 565 
spikes indicate in Figure 8C. 566 
 567 
(iii) We also noted some kinetic differences in the spikes generated by 568 
ACh or K+ stimulation of WT cells. Thus, compared with ACh stimulated cells 569 
(indirect depolarisation through intermittent APs), the K+ stimulated cells 570 
(continuous direct depolarisation) had 27.62% lower rise rate, 27.05% higher 571 
decay time, 21.57% higher t1/2, 12.97% lower Imax and 28.77% higher Q. The 572 
overlapping averaged spikes of Figure 8D indicates a faster but smaller release 573 
of catecholamine when WT cells were stimulated with ACh, compared with K+. 574 
 575 
(iv)  Finally, we compared the kinetic parameters of the secretory 576 
events recorded in mSOD1 cells stimulated with ACh or K+, which showed only 577 
minor differences. For instance, compared with ACh, the K+ elicited spikes had 578 
30.24% higher rise rate, 16.43% lower decay time and 17.81% lower t1/2; the 579 
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rest of the parameters were similar (no statistically significant differences). 580 
Overlapping averaged spikes indicated that the K+ elicited secretory response 581 
was slightly faster but with Q similar to ACh (Figure 8E). 582 
 583 
Spikes with foot were slightly more frequent (10.33%) in ACh stimulated 584 
mSOD1 cells, compared with WT cells (Table 3). Foot duration was 30.8% 585 
longer and had 22.95% lower amplitude in mSOD1 cells compared with WT 586 
cells. No statistically significant differences were observed between both cell 587 
types upon their stimulation with K+ (Table 3). 588 
 589 
Immunoblot analysis of the expression of proteins of the exocytotic machinery 590 
and the α3 subunit of nicotinic receptors in WT and mSOD1 mice. 591 
 592 
 The detailed analysis of the kinetics of amperometric secretory spikes is 593 
contributing to a better understanding of the molecular mechanisms through 594 
which the different proteic components of the exocytotic machinery regulate the 595 
last steps of exocytosis and hence, of neurotransmitter release. In fact, 596 
chromaffin cells from transgenic mice with genetic manipulations of SNARE 597 
proteins have extensively been used to explore specific mutations of those 598 
proteins on the formation and expansion of the fusion pore (58). We therefore 599 
thought of interest to explore the expression of three SNARE proteins and 600 
synaptotagmin in the adrenal medulla, the brain cortex and hippocampus, as 601 
well as the spinal cord of WT and mSOD1 mice. 602 
 603 
 Figure 10 displays the relative densities of SYT7 (A), STX1 (B), SNP25 604 
(C) and VAMP2 (D) in the adrenal medulla of WT and mSOD1 mice. We found 605 
no statistical differences in the relative expression level of SYT7, STX1, SNP25 606 
and VAMP2 in the adrenal medulla between WT and mSOD1; a decreased 607 
20% expression of VAMP2 was at the limit of statistical significance. We also 608 
monitored the expression of the NACHRA3 known to be expressed at high 609 
density in chromaffin cells and to mediate the catecholamine release response 610 
elicited by ACh (7). Figure 10E shows that the NACHRA3 was similarly 611 




 We also tested the expression of proteins in the brain cortex, the 614 
hippocampus and the spinal cord of WT and mSOD1 mice; the results are 615 
summarised in Figure 11. SYT1 density was similar in the cortex and the 616 
hippocampus and was poorly expressed in the spinal cord (panel A). This was 617 
also the case for VAMP2 that had about half density in the spinal cord, 618 
compared with the cortex and the hippocampus (panel D). STX1 and SNP25 619 
were equally expressed in the three brain and spinal cord areas explored 620 
(panels B, C). Concerning WT and mSOD1 tissues, we found no differences in 621 
the expression of SYT1, STX1 and VAMP2 in the cortex, hippocampus and 622 
spinal cord (panels A, B, D). A 25% decrease of SNP25 expression was found 623 
in the spinal cord of mSOD1 mice, with respect to WT mice (panel C; P < 0.05). 624 
In WT mice, some regional statistically significant differences were found; for 625 
instance, STX1 expression was 35% lower in the hippocampus with respect to 626 
motor cortex (Figure 11B).  627 
 628 
Motor deficits of mSOD1 with respect to WT mice 629 
 630 
 In this study we used WT and mSOD1 mice of ages between P90 and 631 
P130 days. At these ages the mutated mice show adult ALS onset (22, 23) and 632 
significant loss of vulnerable spinal motoneurons (9). Although motor 633 
impairment of mSOD1 at these ages is well documented we however explored 634 
the motor activity of the WT and mSOD1 mice used here, by means of the 635 
Rota-Rod test which assesses motor coordination and balance, as described by 636 
Jones and Roberts (28). Animals were placed on the rolling rod (32 mm 637 
diameter) with an initial speed of 8 rpm and an increase of 1 rpm each 8 638 
seconds until they fell down; we made 2 measures of 10 repetitions: the training 639 
day (Trd) and the test day (Td), in two consecutive days, comparing WT and 640 
mSOD1 mice at P90 and P130 ages, as shown in Figure 12.  641 
 642 
mSOD1 mice show a significant decrease in the time they stay on Rota-643 
Rod compared to WT mice in both P90 (panel A, P < 0.05) and P130 (panel B, 644 
P < 0.001) as well as in both, Trds and Tds. Also, when comparing Trd and Td 645 
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we saw mSOD1 mice were not able to improve the time they stay on the rod at 646 
both ages, in contrast with WT mice (P < 0.01). It is remarkable that mSOD1 647 
mice show a significant 56% decrease of the time to fall in P130 compared with 648 





 In this study, pronounced alterations in cell excitability and ion currents, 652 
as well as in the kinetics of the exocytotic fusion pore have been found to occur 653 
in chromaffin cells from mSOD1, in comparison with WT mice. One of the most 654 
notable was the almost disappearance of spontaneous APs, an intrinsic 655 
property of chromaffin cells (12). The resting Vm in bisected mouse adrenal 656 
chromaffin cells using intracellular recordings in situ is 54.3 mV (42). Using the 657 
patch-clamp technique we have found here that WT and mSOD1 had somehow 658 
more hyperpolarised resting Vm, namely −68 mV and −63 mV, respectively. 659 
Considering that the resting Vm was at the same level in both cell types, the 660 
drastic difference in spontaneous firing may find an explanation in the 661 
depressed inward INa as well as in the outward IK(Ca) and IK(V) in mSOD1, with 662 
respect to WT cells, since these currents are known to contribute to the 663 
generation of APs in chromaffin cells (3, 5, 32, 39, 42). 664 
 665 
 Our results on depressed ion currents keep pace with those of the study 666 
of Boutahar et al. (4) dealing with the transcriptional profile of cortical neurons 667 
from E14 embryos of WT and mSOD1 mice. In mSOD1 neurons, the 668 
expression of Na+ channel type VIIα (SNC7A) is depressed 7.2-fold and that of 669 
large-conductance Ca2+-dependent K+ channel (KCNMA1, BK channel) is 670 
depressed by 21-fold with respect to WT neurons. Also, in ALS patients 671 
immunoreactivity of Kv1.2 channels is markedly reduced in the ventral root (57). 672 
Furthermore, SH-SY5Y cells expressing the mutated SOD1G93A have a 673 
decreased INa (66). This depressed gene expression in cortical neurons support 674 
our conclusion that the depressed excitability of mSOD1 chromaffin cells is 675 
likely due to poorer expression of Na+ and K+ channels, thus explaining the 676 
decreased INa and IK we found in these cells. A toxic gain of function has been 677 
considered the cause of motoneuron degeneration on mice overexpressing 678 
human mSOD1 (23). This hypothesis received support from a study on PC12 679 
cells transfected with SOD1G93A that exhibit an increased production of hydroxyl 680 
radicals and an enhanced rate of apoptotic cell death (34). The possibility that 681 
this free radical overproduction is behind the alterations of cell excitability and 682 
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ion currents in mSOD1 chromaffin cells is worth of being explored in further 683 
studies. 684 
 685 
 Bulk secretion of catecholamine measured as the total number of 686 
individual spikes counted during the 1 minute stimulation with ACh, was similar 687 
in both cell types. In principle, this agrees with the similar [Ca2+]c transients 688 
elicited by ACh, in spite of the fact ICa was mildly enhanced in mSOD1 689 
chromaffin cells, in agreement with a previous study showing that N-type 690 
VACCs were overexpressed in cortical neurons of mSOD1 mouse embryos 691 
(49). However, if bulk secretion is measured as a summatory of all spike areas, 692 
it came about that mSOD1 cells secreted 46.6% more catecholamine than WT 693 
cells. This may be explained if the 52.24% higher Q of individual spikes is taken 694 
into account. Similar [Ca2+]c transients and secretion elicited by ACh are not in 695 
agreement with the fact that IACh was 70% smaller in mSOD1 with respect to 696 
WT cells. Because the protein expression of the α3 subunit of nicotinic 697 
receptors is similar in both cell types, the 70% depressed IACh in mSOD1 cells 698 
may be due to an altered receptor function. Compensatory overexpression of 699 
other nicotinic receptor subtypes may also have occurred. This hypothesis 700 
should be pursued in further studies. 701 
 702 
 An interesting difference was found in the kinetic parameters of the 703 
exocytotic fusion pore, averaged from calculations done in thousands of 704 
individual secretory amperometric spikes. These differences are as follows 705 
(mSOD1 versus WT cells): 35.94% lower rise rate, 60.7% higher decay time, 706 
55.3% higher t1/2, 16.61% lower Imax, and 52.24% higher Q. This means that the 707 
expansion of the fusion pore is slower, the release of vesicle contents takes 708 
longer, and the release of catecholamine per vesicle is higher. In other words, 709 
considering the 1 minute period of cell stimulation with ACh, the 21 vesicles that 710 
undergo exocytosis in mSOD1 chromaffin cells release 50% more 711 
catecholamine than the 24-25 vesicles of WT cells, but at a lower rate. 712 
 713 
 Probably, the more striking finding in this study is related to the fact that 714 
the drastic differences in the secretion parameters found between WT and 715 
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mSOD1 cells when stimulated with ACh, were not present when cells were 716 
stimulated with high K+. Since long, ACh, high K+, barium (Ba2+), and several 717 
other secretagogues have been used to trigger exocytosis and even to analyse 718 
the kinetics of the fusion pore (37, 54). However, the physiological 719 
neurotransmitter ACh (19) has been used more rarely simply because 720 
chromaffin cells respond with a healthy secretory response with unphysiological 721 
stimuli such as high K+ or Ba2+ in a more reliable manner. As ACh, these stimuli 722 
certainly cause cell depolarisation (47, 63). However, since the pioneering work 723 
of William Douglas laboratory (16, 17), it has become clear that ACh and K+ 724 
differ in their ability to trigger APs, [Ca2+]c transients, and secretion. For 725 
instance, according to the Nernst equation, high K+ produces a sustained 726 
depolarisation of chromaffin cells without superimposed APs (47). However, 727 
ACh produces a mild depolarisation that serves to trigger APs in chromaffin 728 
cells including mice (3, 5, 11, 12, 20, 26, 42). On the other hand, although ACh 729 
and high K+ elicit similar bulk secretory responses, the former causes more 730 
localised and smaller [Ca2+]c elevations and the latter evokes higher [Ca
2+]c 731 
transients that quickly spread out through the cytosol, as confocal microscopy 732 
reveals (8). 733 
 734 
In the light of those previous results, we may therefore conclude that 735 
chromaffin cells challenged with ACh alters cell excitability and the ensuing 736 
[Ca2+]c transients and secretory responses, in a manner that considerably differ 737 
from the responses elicited by sustained depolarisation with K+. Massive Ca2+ 738 
entry with high K+ suggests that higher unbuffered [Ca2+]c transients occur; this 739 
is not the case for ACh that causes smaller and more localised [Ca2+]c 740 
transients (8). This explains that high K+ causes higher [Ca2+]c transients in 741 
mSOD1 cells, while the ACh [Ca2+]c elevations are similar. Relevant to this 742 
study is that the changes in the kinetics of the exocytotic fusion pore are only 743 
present upon the physiological indirect depolarisation of chromaffin cells 744 
through stimulation of their nicotinic receptors with ACh; those changes are not 745 
seen with direct unphysiological stimulation with high K+. This indicates that an 746 
altered neurotransmission is present at the adrenal medulla of mSOD1 mice. It 747 
will be interesting to test whether WT and mSOD1 mice respond differently to 748 
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cold or hypoglycemic stress before ALS-like disease starts and once the 749 
disease is established. 750 
 751 
 During the last two decades, the analysis of the distinct vesicle pools and 752 
of the pre-exocytotic and exocytotic events in chromaffin cells of transgenic 753 
mice, has been thoroughly applied to understand the molecular and cellular 754 
mechanisms involved in the exocytotic release of neurotransmitters (43, 58, 59). 755 
However, only recently similar studies are being performed in transgenic mouse 756 
models of neurodegenerative diseases. For instance, we found that in 757 
chromaffin cells of the APP/PS1 mouse model of AD, the exocytotic fusion pore 758 
closes faster and releases smaller amount of catecholamine but with a faster 759 
and more transient fusion pore opening, expansion and closure (13). This is just 760 
opposite to what we find here in the mSOD1 mouse model of ALS, where 761 
chromaffin cells exhibit a slower fusion pore kinetics but a greater release of 762 
catecholamine (see the two superimposed averaged AD and ALS secretory 763 
spike models in Figure 8F). The drastic different morphology of both spikes 764 
suggests they can serve as markers for ALS and AD. A recent study also 765 
indicates an alteration of pre-exocytotic and exocytotic steps in chromaffin cells 766 
of a mouse model of HD; this study concludes that the HAP1 regulates 767 
exocytosis via two potentially interlinked mechanisms: control of vesicle docking 768 
and the size of the RRP, and the regulation of fusion pore stabilisation (35). 769 
 770 
 In conclusion, we present here the first study showing a drastic change in 771 
the kinetics of the exocytotic fusion pore in chromaffin cells from the mSOD1 772 
mouse model of ALS, with respect to WT mice, when physiologically challenged 773 
with ACh. A slower fusion pore opening, expansion, and closure is likely due to 774 
a pronounced reduction of cell excitability and ion currents driving APs in 775 
mSOD1 chromaffin cells. These changes may help to better understand human 776 
ALS pathogenesis and to inspire novel biological targets for the eventual 777 
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FIGURE LEGENDS 1009 
 1010 
FIGURE 1. 1011 
Drastic reduction in the number of spontaneous action potentials in mSOD1 1012 
chromaffin cells compared with WT cells. 1013 
 1014 
A, example voltage record obtained from a WT cell. B, voltage record 1015 
obtained from an example mSOD1 cell. C, average action potential 1016 
number recount from 300 s records of WT and mSOD1 cells. D, average 1017 
resting membrane potentials from WT and mSOD1 cells. Data in C and D 1018 
are means ± SEM of the number of cells and cultures shown in 1019 
parentheses. ***P < 0.001 with respect to WT cells (unpaired Student’s t-1020 
test). 1021 
 1022 
FIGURE 2.  1023 
Nicotinic (IACh) and potassium currents (IK) were markedly diminished in voltage-1024 
clamped chromaffin cells from mSOD1 mice, with respect to those from WT 1025 
mice. 1026 
 1027 
Whole-cell inward nicotinic currents (IACh) were generated by 250-ms 1028 
pulses of 100 µM ACh, applied to cells voltage-clamped at −80 mV at 2-1029 
min intervals. Outward K+ currents (IK) were recorded in cells voltage-1030 
clamped at −80 mV and challenged first with a 10-ms depolarising pulse 1031 
to +30 mV to elicit calcium currents (ICa), and subsequently with a 400-1032 
ms depolarising pulse to +120 mV to evoke IK (protocol in panel 2E). A, 1033 
IACh traces obtained in an example WT cell. B, IACh traces obtained in an 1034 
example mSOD1 cell. C, superimposed IACh traces of an example WT 1035 
cell (dark trace) and mSOD1 cell (light trace). D, averaged peak 1036 
amplitude of IACh in WT and mSOD1 cells. E, IK traces from an example 1037 
WT (dark trace) and mSOD1 (light trace) cells exhibiting a large transient 1038 
calcium-dependent K+ current (IK(Ca)) and a smaller non-inactivating 1039 
plateau voltage-dependent K+ current (IK(V)); the pre-pulse and test pulse 1040 
protocol are shown on top. F, average results of the amplitudes of the IK 1041 
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components, IK(Ca) and IK(V) in both cell types. Data in D and F are means 1042 
± SEM of the number of cells and cultures shown in parentheses. **P < 1043 
0.01, ***P < 0.001 with respect to WT cells (unpaired Student’s t-test). 1044 
 1045 
FIGURE 3.  1046 
Augmentation of the whole-cell inward calcium current (ICa) and reduction of the 1047 
whole-cell inward sodium current (INa) in mSOD1 chromaffin cells, with respect 1048 
to WT cells. 1049 
 1050 
To elicit calcium (ICa) and sodium (INa) currents cells were voltage-1051 
clamped at −80 mV and stimulated with 50-ms test depolarising pulses to 1052 
−10 or 0 mV for ICa  and with 10-ms test depolarising pulses to –10 mV 1053 
for INa. A, ICa traces of an example WT (dark trace) and mSOD1 (light 1054 
trace) cells. B, averaged peak amplitude of ICa in WT and mSOD1 cells. 1055 
C, INa traces of an example WT (dark trace) and mSOD1 (light trace) 1056 
cells. D, averaged peak amplitude of INa in WT and mSOD1 cells. Data in 1057 
B and D are means ± SEM of the number of cells and cultures shown in 1058 
parentheses. **P < 0.01 with respect to WT cells (unpaired Student’s t-1059 
test). 1060 
 1061 
FIGURE 4. 1062 
Elevations of the cytosolic Ca2+ concentrations ([Ca2+]c) elicited by 1 min 1063 
challenging with acetylcholine (ACh) of high potassium (K+) in WT and mSOD1 1064 
chromaffin cells. 1065 
 1066 
Fura-2AM loaded cells were perifused for 1 min with saline solutions 1067 
containing 100 µM ACh (A) or 75 mM K+ (low Na+, B), as indicated by 1068 
horizontal lines at the bottom. A and B, overlapping [Ca2+]c traces 1069 
(expressed as arbitrary fluorescence units, AFU) obtained in example 1070 
WT and mSOD1 cells. Averaged pooled results of time to peak of the 1071 
[Ca2+]c elevation (C), peak amplitude (D) and area (E) as indication of the 1072 
total [Ca2+]c transient of WT and mSOD1 cells. Data are means ± SEM of 1073 
the number of cells shown in parentheses on top of panel C, from at least 1074 
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3 different cultures. ***P < 0.001 (one-way ANOVA test and Tukey post-1075 
hoc analyses). 1076 
 1077 
FIGURE 5.  1078 
Higher total catecholamine release in mSOD1 chromaffin cells compared with 1079 
WT cells stimulated with acetylcholine (ACh).  1080 
 1081 
A, example record obtained from a WT cell stimulated with 100 µM ACh 1082 
for 1 min (bottom horizontal bar). B, record obtained from an example 1083 
mSOD1 cell similarly stimulated with ACh. C, cumulative secretion 1084 
calculated at 5 s intervals in traces similar to those shown in A and B; the 1085 
area of spikes is expressed in pC (ordinate) as a function of time 1086 
(abscissa). D, secretion per stimulation period (integrated area of all 1087 
spikes generated by the ACh pulse) in pC (ordinate). E, total number of 1088 
spikes secreted per each ACh pulse (ordinate). F, quantal size of 1089 
individual secretory events expressed in pC (ordinate). Data in C, D, E 1090 
are means ± SEM of the number of cells and cultures shown in 1091 
parentheses. Data in F are means ± SEM of the number of individual 1092 
spikes shown in parentheses; those spikes are from the experiments of D 1093 
and E. *P < 0.05, ***P < 0.001 with respect to WT cells (unpaired 1094 
Student’s t-test). 1095 
 1096 
FIGURE 6.  1097 
Similar total catecholamine release in mSOD1 chromaffin cells compared with 1098 
WT cells stimulated with high potassium (K+).  1099 
 1100 
A, example record obtained from a WT cell stimulated with 75 mM K+ 1101 
(low Na+) for 1 min (bottom horizontal bar). B, record obtained from an 1102 
example mSOD1 cell similarly stimulated with K+. C, cumulative secretion 1103 
calculated at 5 s intervals in traces similar to those shown in A and B; the 1104 
area of spikes is expressed in pC (ordinate) as a function of time 1105 
(abscissa). D, secretion per stimulation period (integrated area of all 1106 
spikes generated by the K+ pulse) in pC (ordinate). E, total number of 1107 
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spikes secreted per each K+ pulse (ordinate). F, quantal size of individual 1108 
secretory events expressed in pC (ordinate). Data in C, D and E are 1109 
means ± SEM of the number of cells and cell cultures shown in 1110 
parentheses. Data in F are means ± SEM of the number of individual 1111 
spikes shown in parentheses; those spikes are from the experiments of D 1112 
and E. There are no significant differences between WT and mSOD1 1113 
cells (unpaired Student’s t-test). 1114 
 1115 
FIGURE 7.  1116 
Histograms of spike frequency versus time analysed on secretory traces 1117 
obtained from WT and mSOD1 chromaffin cells stimulated with acetylcholine 1118 
(ACh) or high potassium (K+). 1119 
 1120 
A,B, frequency histograms of spike frequency (ordinates) versus time 1121 
(abscissa) challenged with ACh in WT and mSOD1 cells. C,D, frequency 1122 
histograms of spike frequency (ordinates) versus time (abscissa) 1123 
challenged with 75 mM K+ (low Na+) in WT and mSOD1 cells. E, time 1124 
constant for inactivation (τi, ordinate in seconds) calculated from the 1125 
decay of spike frequency of panels A,B,C,D. Data in panel E are means 1126 
± SEM of the number of cells and cell cultures shown in parentheses in 1127 
panels A to D. *P < 0.05 (unpaired Student’s t-test). 1128 
 1129 
FIGURE 8.  1130 
Prototype spike shapes obtained from averaged pooled data on the kinetic 1131 
parameters of individual exocytotic spike events taken from experiments of 1132 
Figures 5 and 6 and summarised in Table 1, done in chromaffin cells from WT 1133 
and mSOD1 mice. 1134 
 1135 
A, spike model showing the kinetic parameters calculated for the foot 1136 
(Table 3) and the spike (Table 1). B, superimposed averaged spikes for 1137 
WT (continuous line) and mSOD1 cells (discontinuous line) stimulated 1138 
with ACh (100 µM); C, superimposed averaged spikes for cells of WT 1139 
(continuous line) and mSOD1 (discontinuous line) stimulated with K+ (75 1140 
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mM, low Na+); D, superimposed averaged spikes for WT cells stimulated 1141 
with ACh (continuous line) or K+ (discontinuous line); E, superimposed 1142 
averaged spikes for mSOD1 cells stimulated with ACh (continuous line) 1143 
and K+ (discontinuous line). F, overlapping averaged spikes from 1144 
chromaffin cells from APP/PS1 mice model of AD (discontinuous line, 1145 
taken from de Diego et al., 2012) and an ALS mouse model (continuous 1146 
line, from this study). 1147 
 1148 
FIGURE 9.  1149 
Types of secretory spike events in chromaffin cells from WT and mSOD1 mice 1150 
stimulated with ACh or K+.  1151 
 1152 
Example spike events were selected from secretory traces from 1153 
experiments of Figures 5 and 6. A, spike with foot (left) and stand-alone 1154 
spike (right) of a WT cell stimulated with ACh (100 µM); B, overlapping 1155 
spikes in a WT cell stimulated with ACh; C, overlapping spikes and 1156 
partial fusion pore (flicker) followed by a spike (full fusion pore) of a WT 1157 
cell stimulated with K+ (75 mM, low Na+); D, spike with foot (left) and 1158 
stand-alone spike of a mSOD1 cell stimulated with ACh (right); E, 1159 
transient fusion pore (flicker) and overlapping spikes of a mSOD1 cell 1160 
stimulated with ACh; F, flicker and overlapping spikes in a mSOD1 cell 1161 
stimulated with K+. Quantitative pooled data on the frequency of these 1162 
exocytotic spike events are summarised in Table 2. 1163 
 1164 
FIGURE 10. 1165 
Relative expression of proteins of the exocytotic machinery and the α3 subunit 1166 
of nicotinic receptors in adrenal medullary tissue from WT and mSOD1 mice, 1167 
monitored with western blot. 1168 
 1169 
An immunoblot from a representative experiment is shown on the top of 1170 
each panel. Top bands correspond to synaptotagmin 7 (SYT7, panel A), 1171 
syntaxin 1 (STX1, panel B), synaptosomal-associated protein 25 1 1172 
(SNP25, panel C), vesicle-associated membrane protein 2 (VAMP2, 1173 
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panel D) and neuronal acetylcholine receptor subunit α3 (NACHRA3, 1174 
panel E); lower bands correspond to control β-actin (ACTB). Bar 1175 
diagrams represent pooled averaged results of adrenal glands from WT 1176 
and mSOD1 mice. The relative band densities were calculated as ratios 1177 
between the density of each band protein and its corresponding ACTB 1178 
band, within each individual immunoblot. Values are means ± SEM. 1179 
There are not significant differences between WT and mSOD1 mice 1180 
(unpaired Student’s t-test). 1181 
 1182 
FIGURE 11. 1183 
Relative expression of proteins of the exocytotic machinery and the α3 subunit 1184 
of nicotinic receptors in the motor cortex, the hippocampus and the spinal cord 1185 
from WT and mSOD1 mice, monitored with western blot.  1186 
 1187 
An immunoblot from a representative experiment is shown on the top of 1188 
each panel. Top bands correspond to synaptotagmin 1 (SYT1, panel A), 1189 
syntaxin 1 (STX1, panel B), synaptosomal-associated protein 25 1 1190 
(SNP25, panel C), vesicle-associated membrane protein 2 (VAMP2, 1191 
panel D) and neuronal acetylcholine receptor subunit α3 (NACHRA3, 1192 
panel E); lower bands correspond to control β-actin (ACTB). Bar 1193 
diagrams represent pooled averaged results motor cortex, hippocampus 1194 
and spinal cord from WT and mSOD1 mice. The relative band densities 1195 
were calculated as ratios between the density of each band protein and 1196 
its corresponding ACTB band, within each individual immunoblot. Values 1197 
are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (one-way 1198 
ANOVA/Newmann-Keuls); #P < 0.05 (unpaired Student’s t-test). 1199 
 1200 
FIGURE 12. 1201 
Time standing on Rota-Rod diminishes in mSOD1 mice with respect to WT 1202 
mice and is age-dependent. 1203 
  1204 
Mice were placed onto Rota-Rod and challenged with an initial speed of 1205 
8 rpm and an increase of 1 rpm each 8 seconds until they fell down; we 1206 
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made 2 measures of 10 repetitions: during the training day (Trd) and the 1207 
test day (Td), in two consecutive days. A, WT (white bars) and mSOD1 1208 
(black bars) mice used were at postnatal day 90 comparing Trd (stripped 1209 
bars) and Td (plain bars). B, WT (white bars) and mSOD1 (black bars) 1210 
mice used were at postnatal day 130 comparing Trd (stripped bars) and 1211 
Td (plain bars). C, Comparison between Tds of WT (white bars) and 1212 
mSOD1 (black bars) mice. Data are means ± SEM of the number of mice 1213 
shown in parentheses. *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired 1214 
Student’s t-test).  1215 
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TABLE LEGENDS 1216 
 1217 
TABLE 1. 1218 
Single spike kinetic parameters calculated from the secretory traces obtained in 1219 
WT and mSOD1 chromaffin cells stimulated with ACh (100 µM) or K+ (75 mM) 1220 
for 1 min. 1221 
 1222 
Individual spike data in each cell were analysed and averaged; hence, 1223 
final averaged data are expressed as the means of all cells (in 1224 
parentheses). Rise rate was calculated with the slope of the ascending 1225 
spike phase; decay time was calculated from the time between 75% and 1226 
25% of spike height in the descending spike phase; t1/2 is the width of the 1227 
spike at 50% of spike height; Imax is the height of the spike; Q is the spike 1228 
area, an indication of catecholamine vesicle content and release (quantal 1229 
size). Chromaffin cells from WT and mSOD1 mice were compared for 1230 
each single spike parameter (columns) using the nonparametric Mann-1231 
Whitney rank sum test. Significant differences between both cell types 1232 
are symbolised with asterisks in the mSOD1 row. Data are presented as 1233 
means ± SEM with relative change of mSOD1 respect to WT (in mSOD1-1234 
ACh row) or relative change of K+ respect to ACh (in K+ rows) given in 1235 
parentheses. Statistical tests were performed using the mean of at least 1236 
10 spikes per cell for each parameter. *P < 0.05, **P < 0.01, ***P < 0.001 1237 
in mSOD1 with respect to WT chromaffin cells for each stimulus; #P < 1238 
0.05, ##P < 0.01, ###P < 0.001 in K+ with respect to ACh stimulus for each 1239 
cell type (unpaired Student’s t-test in both cases). 1240 
 1241 
TABLE 2. 1242 
Characteristics of exocytotic spike events in WT and mSOD1 chromaffin cells 1243 
stimulated with ACh (100 µM) or K+ (75 mM) for 1 min.  1244 
 1245 
Data were obtained through the manual analysis of secretory event 1246 
traces obtained from experiments shown in Figures 5A,B (ACh) and 6A,B 1247 
(K+), counting the different types of events as displayed in Figure 9. Data 1248 
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are presented as means ± SEM with relative change of mSOD1 respect 1249 
to WT (in mSOD1-ACh row) or relative change of K+ respect to ACh (in 1250 
K+ rows) given in parentheses. *P < 0.05 in mSOD1 with respect to WT 1251 
chromaffin cells for each stimulus; ##P < 0.01 in K+ with respect to ACh 1252 
stimulus for each cell type (unpaired Student’s t-test in both cases). 1253 
 1254 
TABLE 3. 1255 
Kinetic parameters of feet found at the beginning of single amperometric events 1256 
in the secretory traces obtained in WT and mSOD1 chromaffin cells stimulated 1257 
with ACh (100 µM) or K+ (75 mM) for 1 min. 1258 
 1259 
tfoot is the duration of the foot, Ifoot is foot height; Qfoot is the area of the 1260 
foot (catecholamine release during the foot). Chromaffin cells from WT 1261 
and mSOD1 mice were compared for each single-spike foot parameter 1262 
(columns) using the nonparametric Mann-Whitney rank sum test. 1263 
Significant differences between both cell types are symbolised with 1264 
asterisks in the mSOD1 row. Data are presented as means ± SEM with 1265 
relative change of mSOD1 respect to WT (in mSOD1-ACh row) or 1266 
relative change of K+ respect to ACh (in K+ rows) given in parentheses. 1267 
Statistical tests were performed using the mean of at least 10 spikes per 1268 
cell for each parameter. *P < 0.05, ***P < 0.001 in mSOD1 with respect 1269 
to WT chromaffin cells for each stimulus; #P < 0.05, ##P < 0.01, ###P < 1270 
0.001 in K+ with respect to ACh stimulus for each cell type (unpaired 1271 
























































































t1/2                                            
(ms) 
Imax                            
(pA) 









15.21 ± 1.15 ** 
(35.94% lower) 
9.73 ± 0.6 *** 
(60.7% higher) 
8.86 ± 0.56 *** 
(55.3% higher) 
32.72 ± 2.08 * 
(16.62% lower) 



















34.16 ± 1.88 
(12.97% lower) 





















36.69 ± 2.07              
(12.12% higher) 










Spikes with                       
foot (%) 
Multiple-spike        
events (%) 
Flickering                     
(%) 
WT (ACh) 2034 (63) 59.56 ± 2.17 3.91 ± 0.46 6.9 ± 0.88 
mSOD1 (ACh) 1357 (69) 
65.71 ± 1.91 *     
(10.33% higher) 
4.15 ± 0.55      
(6.14% higher) 




) 1848 (58) 
67.94 ± 2.28 
##
  
   
(14.08% higher) 
5.69 ± 0.74                
(45.52% higher) 




) 1761 (74) 
73.12 ± 1.72 
##
                 
(11.27% higher) 
5.09 ± 0.57              
(22.65% higher) 











Spikes with               
foot (%) 
tfoot                  
(ms) 
Ifoot                                      
(pA) 
Qfoot                                  
(fC) 
WT (ACh) 2034 (63) 59.56 ± 2.17 3.6 ± 0.3 3.73 ± 0.22 17.08 ± 1.59 
mSOD1 (ACh) 1357 (69) 
65.71 ± 1.91 *     
(10.33% higher) 
4.7 ± 0.26 ***  
(30.8% higher) 
2.87 ± 0.14 *** 
(22.95% lower) 




) 1848 (58) 
67.94 ± 2.28 
##    
(14.08% higher) 












) 1761 (74) 
73.12 ± 1.72 
##
                 
(11.27% higher) 




3 ± 0.14                       
(4.25% higher) 
15.75 ± 1.49 
(3.69% lower) 
 
